The Marcus (MCS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Nov, 2025Executive summary
Fiscal 2025 Q1 revenues rose 7.4% year-over-year to $148.8M, aided by four extra operating days from a fiscal calendar change.
Operating loss widened to $20.4M, impacted by higher labor, depreciation, and stock-based compensation, partially offset by asset sales.
Net loss increased to $16.8M from $11.9M, with diluted EPS at $(0.54) versus $(0.38) prior year.
Adjusted EBITDA was a loss of $0.3M, down from a $2.3M gain last year, mainly due to higher costs.
Over $25M was returned to shareholders in the past four quarters, including $7.1M in Q1 share repurchases.
Financial highlights
Consolidated revenue increased by $10.2M year-over-year, with $9.2M attributed to the calendar change.
Total costs and expenses rose to $169.2M from $155.2M, driven by higher labor, film costs, and depreciation.
Cash flow from operations was a use of $35.3M, compared to $15.1M last year, due to timing of payables and lower EBITDA.
Capital expenditures were $23M, mainly for Hilton Milwaukee renovation and theatre maintenance.
Cash and equivalents at quarter-end were $11.9M, with over $180M available under the revolver.
Outlook and guidance
Full-year outlook remains positive, with expected growth in both theaters and hotels, and a strong film slate through 2026.
Hotels expect continued group and event business growth, with bookings and banquet pace ahead of last year.
Fiscal 2025 effective tax rate expected in the 28–32% range.
Capital expenditures for fiscal 2025 projected at $70–$85M.
Leisure travel demand may soften near-term, but group business remains stable.
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025